Skip to main content
Equibles
AMGN logo

AMGN · Amgen Inc · Metrics

Track AMGN — free

Use AMGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$383.69 -7.58 (-1.94%)
S&P 500 member Nasdaq-100 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$211.53B
Shares
540.63M

AMGN metrics

101 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$391.27
Market cap
$211.53B

Price action

20 metrics
Price change (1W)
-10.3%
Price change (30D)
-5.8%
Price change (3M)
+14.1%
Price change (6M)
+4.7%
Price change (YTD)
+20.1%
Price change (1Y)
+40.3%
Trailing year
Price change (5Y)
+78.0%
52-week high
$444.12
52-week low
$271.18
Change from 52-week high
-11.5%
Change from 52-week low
+45.0%
Annualized volatility
29.5%
Annualized volatility (3M)
33.8%
Beta
0.6
RSI (14D)
36.8
Price vs SMA 50
-1.2%
Price vs SMA 200
+9.6%
Avg volume (3M)
2.73M
Relative volume
2.5
Average dollar volume
$1.05B

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
540.63M

Valuation

12 metrics
P / E (TTM)
24.4
Trailing earnings · reciprocal yield 4.1%
PEG ratio
0.4
EV / revenue
6.9×
reciprocal yield 14.5%
EV / EBITDA
16.1×
reciprocal yield 6.2%
EV / EBIT
23.0×
reciprocal yield 4.3%
P / sales
5.8×
reciprocal yield 17.4%
P / book
18.8
reciprocal yield 5.3%
FCF yield
4.6%
TTM · current market cap
Buyback yield
0.0%
P / FCF
21.6
reciprocal yield 4.6%
P / operating cash flow
17.6
reciprocal yield 5.7%
Earnings yield
4.0%

Historical valuation

8 metrics
P / E historical average (3Y)
30.6×
reciprocal yield 3.3%
P / E historical average (5Y)
26.5×
reciprocal yield 3.8%
EV / revenue historical average (3Y)
6.5×
reciprocal yield 15.3%
EV / revenue historical average (5Y)
6.3×
reciprocal yield 15.8%
EV / EBIT historical average (3Y)
27.0×
reciprocal yield 3.7%
EV / EBIT historical average (5Y)
23.5×
reciprocal yield 4.3%
EV / EBITDA historical average (3Y)
18.9×
reciprocal yield 5.3%
EV / EBITDA historical average (5Y)
16.7×
reciprocal yield 6.0%

Dividends & buybacks

7 metrics
Dividend yield
2.5%
Trailing 12 months
Payout ratio
60.4%
Shareholder yield
—
Dividend / share (TTM)
$9.94
Dividend growth YoY
+5.9%
Dividend growth streak
5
Last ex-dividend
2026-08-21

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
67.2%
Operating margin
30.0%
Trailing 12 months
Net margin
23.0%
Gross profit (TTM)
$18.08B
Operating profit (TTM)
$11.43B
Net income (TTM)
$8.74B
Trailing 12 months
Diluted EPS (TTM)
$16.09
FCF margin
26.7%
Effective tax rate
15.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$16.07

Growth

11 metrics
Revenue growth YoY
+9.5%
Year over year
Net income growth YoY
+65.9%
Revenue (TTM)
$38.09B
Trailing 12 months
EPS growth YoY
+64.9%
Shares change YoY
+0.6%
Year over year · more shares
Revenue CAGR (3Y)
+11.8%
Revenue CAGR (5Y)
+7.6%
EPS CAGR (3Y)
+5.5%
EPS CAGR (5Y)
+2.9%
FCF CAGR (3Y)
-2.7%
FCF CAGR (5Y)
-3.9%

Quality

14 metrics
Return on equity
74.8%
Return on assets
9.1%
Debt / equity
4.9
Current ratio
1.4
EBITDA (TTM)
$16.32B
Free cash flow (TTM)
$10.18B
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
2.7
Return on invested capital
17.7%
Trailing 12 months
Net cash
−$43.31B
Latest balance sheet
Cash & equivalents
$13.99B
Total assets
$95.64B
Total debt
$57.30B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$12.48B
Capital expenditures (TTM)
$2.30B
R&D (TTM)
$7.63B
SG&A (TTM)
$7.02B
Stock compensation (TTM)
$492.00M
R&D / revenue
20.0%
Stock compensation / revenue
1.3%

Ownership (13F)

3 metrics
13F filers
3,165
13F filer change QoQ
+7
Institutional ownership
84.4%

Short interest

3 metrics
Short interest
2.2%
Latest settlement · 4.3 days to cover
Days to cover
4.3d
Short-squeeze score
47 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.11M
Insider-sentiment score
31 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 318154 CUSIP 031162100 13F (30d) 1003 filings 954 filers Visit website Investor relations